FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324019042> ?p ?o ?g. }

• W4324019042 endingPage "219" @default.
• W4324019042 startingPage "210" @default.
• W4324019042 abstract "Small molecule Bruton's tyrosine kinase (BTK) inhibitors have been developed for the treatment of various haemato-oncological diseases, and ibrutinib was approved as the first BTK inhibitor for anticancer therapy in 2013. Previous reports proved the receptor kinase human epidermal growth factor receptor 2 (HER2) to be a valid off-target kinase of ibrutinib and potentially other irreversible BTK inhibitors, as it possesses a druggable cysteine residue in the active site of the enzyme. These findings suggest ibrutinib as a candidate drug for repositioning in HER2-positive breast cancer (BCa). This subtype of breast cancer belongs to one of the most common classes of breast tumours, and its prognosis is characterized by a high rate of recurrence and tumour invasiveness. Based on their similar kinase selectivity profiles, we investigated the anticancer effect of zanubrutinib, evobrutinib, tirabrutinib and acalabrutinib in different BCa cell lines and sought to determine whether it is linked with targeting the epidermal growth factor receptor family (ERBB) pathway. We found that zanubrutinib is a potential inhibitor of the HER2 signalling pathway, displaying an antiproliferative effect in HER2-positive BCa cell lines. Zanubrutinib effectively inhibits the phosphorylation of proteins in the ERBB signalling cascade, including the downstream kinases Akt and ERK, which mediate key signals ensuring the survival and proliferation of cancer cells. We thus propose zanubrutinib as another suitable candidate for repurposing in HER2-amplified solid tumours." @default.
• W4324019042 created "2023-03-14" @default.
• W4324019042 creator A5013262483 @default.
• W4324019042 creator A5062283022 @default.
• W4324019042 creator A5083504203 @default.
• W4324019042 creator A5087395557 @default.
• W4324019042 date "2023-03-13" @default.
• W4324019042 modified "2023-09-27" @default.
• W4324019042 title "Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines" @default.
• W4324019042 cites W1943920605 @default.
• W4324019042 cites W1988142400 @default.
• W4324019042 cites W1999314540 @default.
• W4324019042 cites W2016775461 @default.
• W4324019042 cites W2039432759 @default.
• W4324019042 cites W2043345702 @default.
• W4324019042 cites W2049848617 @default.
• W4324019042 cites W2062482627 @default.
• W4324019042 cites W2077550665 @default.
• W4324019042 cites W2104239861 @default.
• W4324019042 cites W2121859894 @default.
• W4324019042 cites W2167121370 @default.
• W4324019042 cites W2213952892 @default.
• W4324019042 cites W2416897715 @default.
• W4324019042 cites W2514059094 @default.
• W4324019042 cites W2525969549 @default.
• W4324019042 cites W2600231501 @default.
• W4324019042 cites W2627019357 @default.
• W4324019042 cites W2756562465 @default.
• W4324019042 cites W2766636943 @default.
• W4324019042 cites W2788356134 @default.
• W4324019042 cites W2793190614 @default.
• W4324019042 cites W2805329287 @default.
• W4324019042 cites W2914323946 @default.
• W4324019042 cites W2945653412 @default.
• W4324019042 cites W2964310707 @default.
• W4324019042 cites W2966475886 @default.
• W4324019042 cites W2972482801 @default.
• W4324019042 cites W3008628679 @default.
• W4324019042 cites W3021411361 @default.
• W4324019042 cites W3139157067 @default.
• W4324019042 cites W3140065984 @default.
• W4324019042 cites W3161634313 @default.
• W4324019042 cites W3193981255 @default.
• W4324019042 cites W3211754881 @default.
• W4324019042 cites W4306850077 @default.
• W4324019042 doi "https://doi.org/10.1007/s10637-023-01346-7" @default.
• W4324019042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36913160" @default.
• W4324019042 hasPublicationYear "2023" @default.
• W4324019042 type Work @default.
• W4324019042 citedByCount "0" @default.
• W4324019042 crossrefType "journal-article" @default.
• W4324019042 hasAuthorship W4324019042A5013262483 @default.
• W4324019042 hasAuthorship W4324019042A5062283022 @default.
• W4324019042 hasAuthorship W4324019042A5083504203 @default.
• W4324019042 hasAuthorship W4324019042A5087395557 @default.
• W4324019042 hasBestOaLocation W43240190421 @default.
• W4324019042 hasConcept C101544691 @default.
• W4324019042 hasConcept C121608353 @default.
• W4324019042 hasConcept C126322002 @default.
• W4324019042 hasConcept C184235292 @default.
• W4324019042 hasConcept C185592680 @default.
• W4324019042 hasConcept C203014093 @default.
• W4324019042 hasConcept C2777938653 @default.
• W4324019042 hasConcept C2778461978 @default.
• W4324019042 hasConcept C2779251935 @default.
• W4324019042 hasConcept C2779438470 @default.
• W4324019042 hasConcept C2779878957 @default.
• W4324019042 hasConcept C42362537 @default.
• W4324019042 hasConcept C502942594 @default.
• W4324019042 hasConcept C55493867 @default.
• W4324019042 hasConcept C62478195 @default.
• W4324019042 hasConcept C71924100 @default.
• W4324019042 hasConcept C75217442 @default.
• W4324019042 hasConcept C86803240 @default.
• W4324019042 hasConcept C90059517 @default.
• W4324019042 hasConcept C98274493 @default.
• W4324019042 hasConceptScore W4324019042C101544691 @default.
• W4324019042 hasConceptScore W4324019042C121608353 @default.
• W4324019042 hasConceptScore W4324019042C126322002 @default.
• W4324019042 hasConceptScore W4324019042C184235292 @default.
• W4324019042 hasConceptScore W4324019042C185592680 @default.
• W4324019042 hasConceptScore W4324019042C203014093 @default.
• W4324019042 hasConceptScore W4324019042C2777938653 @default.
• W4324019042 hasConceptScore W4324019042C2778461978 @default.
• W4324019042 hasConceptScore W4324019042C2779251935 @default.
• W4324019042 hasConceptScore W4324019042C2779438470 @default.
• W4324019042 hasConceptScore W4324019042C2779878957 @default.
• W4324019042 hasConceptScore W4324019042C42362537 @default.
• W4324019042 hasConceptScore W4324019042C502942594 @default.
• W4324019042 hasConceptScore W4324019042C55493867 @default.
• W4324019042 hasConceptScore W4324019042C62478195 @default.
• W4324019042 hasConceptScore W4324019042C71924100 @default.
• W4324019042 hasConceptScore W4324019042C75217442 @default.
• W4324019042 hasConceptScore W4324019042C86803240 @default.
• W4324019042 hasConceptScore W4324019042C90059517 @default.
• W4324019042 hasConceptScore W4324019042C98274493 @default.
• W4324019042 hasFunder F4320321005 @default.
• W4324019042 hasFunder F4320321006 @default.

• next